SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Trovagene Inc., a San Diego molecular diagnostics company, announced that it has entered into a clinical collaboration with the University of California, San Diego's Moores Cancer Center.
San Diego-based Arcturus Therapeutics and Canadian company Precision NanoSystems announced a partnership for the manufacture of RNA medicines.
San Diego-based AMN Healthcare Services Inc., a health care staffing company, announced the completion of the previously announced acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH LLC for a total purchase price of $82.5 million.
The California Legislature had an active year, adding 930 new laws that will come into effect in 2015 – many of which aim to reform the state’s health care industry. These come as the federal health care reform hits businesses in a big way this year.
BIOTECH: Firm’s Hemopurifier Makes A Top Invention List
San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced that the U.S. Food and Drug Administration has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Aethlon Hemopurifier.
BIOTECH: Markers Are Measured on Molecular Level
Notable investors, and even a Hollywood star, are betting millions on the Cue, a diagnostic device and consumer health product that may one day be as ubiquitous as the household thermometer.
Trovagene Inc., a San Diego molecular diagnostics company, announced that it has entered into a clinical collaboration with Los Angeles-based City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases
San Diego-based Ansun Biopharma Inc. will pay about $2 million to settle civil and criminal complaints about submitting false and fraudulent claims on grants and a contract with the National Institutes of Health (NIH).
Suneva Medical Inc., a San Diego-based aesthetics company, announced that the U.S. Food and Drug Administration (FDA) has approved its dermal filler, Bellafill, for the treatment of acne scars.
Johnson & Johnson has signed an $835 million pact with Carlsbad-based Isis Pharmaceuticals Inc., joining a growing list of big companies allied with the local company’s research and development group.
DexCom Inc. announced that Kevin Sayer, currently the company's president and chief operating officer, has assumed the role of president and chief executive officer.
San Diego-based GlySens Inc., a medical technology company, announced Monday that it has closed a $12 million Series C investment round.
San Diego-based PocketDerm LLC, a dermatology-targeted telehealth startup, has raised $2.85 million from the sale of securities, according to a recent regulatory filing with the Securities and Exchange Commission.
San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Aethlon Hemopurifier.
Kaiser Permanente’s 2,600 California mental health clinicians — psychologists, therapists and social workers represented by the National Union of Healthcare Workers (NUHW) — will launch a statewide strike on Monday, Jan. 12, to protest Kaiser’s alleged failure to provide its patients with timely, quality mental health care, according to a recent press release issued by the NUHW.